Terms: = Bone cancer AND CARS, P49589, 833, ENSG00000110619
114 results:
1. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850).
Kimura T; Okada K; Morohashi Y; Kato Y; Mori M; Kato H; Matsumoto T; Shimoyama S
Pharm Res; 2024 Apr; 41(4):795-806. PubMed ID: 38536615
[TBL] [Abstract] [Full Text] [Related]
2. A grayscale compression method to segment bone structures for 2D-3D registration of setup images in non-coplanar radiotherapy.
Song Z; Li T; Zuo L; Song Y; Wei R; Dai J
Biomed Phys Eng Express; 2024 Mar; 10(3):. PubMed ID: 38442730
[No Abstract] [Full Text] [Related]
3. Ct-based intratumoral and peritumoral radiomics for predicting prognosis in osteosarcoma: A multicenter study.
Su Q; Wang N; Wang B; Wang Y; Dai Z; Zhao X; Li X; Li Q; Yang G; Nie P
Eur J Radiol; 2024 Mar; 172():111350. PubMed ID: 38309216
[TBL] [Abstract] [Full Text] [Related]
4. A second-generation M1-polarized CAR macrophage with antitumor efficacy.
Lei A; Yu H; Lu S; Lu H; Ding X; Tan T; Zhang H; Zhu M; Tian L; Wang X; Su S; Xue D; Zhang S; Zhao W; Chen Y; Xie W; Zhang L; Zhu Y; Zhao J; Jiang W; Church G; Chan FK; Gao Z; Zhang J
Nat Immunol; 2024 Jan; 25(1):102-116. PubMed ID: 38012418
[TBL] [Abstract] [Full Text] [Related]
5. Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review).
Kausar MA; Anwar S; El-Horany HE; Khan FH; Tyagi N; Najm MZ; Sadaf ; Eisa AA; Dhara C; Gantayat S
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37830150
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine kinase signaling-independent MET-targeting with CAR-T cells.
Qin A; Qin Y; Lee J; Musket A; Ying M; Krenciute G; Marincola FM; Yao ZQ; Musich PR; Xie Q
J Transl Med; 2023 Oct; 21(1):682. PubMed ID: 37779207
[TBL] [Abstract] [Full Text] [Related]
7. The future of CAR T-cell therapy for B-cell acute lymphoblastic leukemia in pediatrics and adolescents.
Schultz L; Mackall CL
Expert Opin Biol Ther; 2023; 23(7):633-640. PubMed ID: 37326236
[TBL] [Abstract] [Full Text] [Related]
8. Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice.
Pfeifer R; Al Rawashdeh W; Brauner J; Martinez-Osuna M; Lock D; Herbel C; Eckardt D; Assenmacher M; Bosio A; Hardt OT; Johnston ICD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298141
[TBL] [Abstract] [Full Text] [Related]
9. Studies related to osteosarcoma and metabolism from 1990 to 2022: A visual analysis and bibliometric study.
Shao Z; Bi S
Front Endocrinol (Lausanne); 2023; 14():1144747. PubMed ID: 36950694
[TBL] [Abstract] [Full Text] [Related]
10. Ghost Cell Odontogenic Carcinoma: A Case Report and Literature Review.
Nakhla MN; Richards PQ; Miller JE; Afework D; Manzoor D; Lin YL; Aghaloo T; Blackwell KE; St John MA
Laryngoscope; 2023 Apr; 133(4):830-833. PubMed ID: 36533581
[TBL] [Abstract] [Full Text] [Related]
11. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours.
Flugel CL; Majzner RG; Krenciute G; Dotti G; Riddell SR; Wagner DL; Abou-El-Enein M
Nat Rev Clin Oncol; 2023 Jan; 20(1):49-62. PubMed ID: 36418477
[TBL] [Abstract] [Full Text] [Related]
12. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
Liu Z; Liu H; Wang D
Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
14. Road testing new CAR design strategies in multiple myeloma.
Rana PS; Murphy EV; Kort J; Driscoll JJ
Front Immunol; 2022; 13():957157. PubMed ID: 36016950
[TBL] [Abstract] [Full Text] [Related]
15. Stereotactic Body Radiation Therapy for Metastases in Long bones.
Madani I; Sahgal A; Erler D; Stish BJ; Olivier KR; Park SS; Eppinga WSC; Seravalli E; Redmond KJ; Cao Y; Siva S; Chang D; Nguyen TK; O'Neil M; Guckenberger M
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):738-746. PubMed ID: 35850362
[TBL] [Abstract] [Full Text] [Related]
16. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Liu AJ; Kosiorek HE; Ueberroth BE; Jaeger E; Ledet E; Kendi AT; Tzou K; Quevedo F; Choo R; Moore CN; Ho TH; Singh P; Keole SR; Wong WW; Sartor O; Bryce AH
Prostate; 2022 Sep; 82(12):1202-1209. PubMed ID: 35652618
[TBL] [Abstract] [Full Text] [Related]
17. Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models.
Mu-Mosley H; Ostermann L; Muftuoglu M; Vaidya A; Bonifant CL; Velasquez MP; Gottschalk S; Andreeff M
Front Immunol; 2022; 13():880108. PubMed ID: 35615350
[TBL] [Abstract] [Full Text] [Related]
18. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Talleur AC; Qudeimat A; Métais JY; Langfitt D; Mamcarz E; Crawford JC; Huang S; Cheng C; Hurley C; Madden R; Sharma A; Suliman A; Srinivasan A; Velasquez MP; Obeng EA; Willis C; Akel S; Karol SE; Inaba H; Bragg A; Zheng W; Zhou SM; Schell S; Tuggle-Brown M; Cullins D; Patil SL; Li Y; Thomas PG; Zebley C; Youngblood B; Pui CH; Lockey T; Geiger TL; Meagher MM; Triplett BM; Gottschalk S
Blood Adv; 2022 Nov; 6(21):5737-5749. PubMed ID: 35446934
[TBL] [Abstract] [Full Text] [Related]
19. Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy.
An L; Lin Y; Deng B; Yin Z; Zhao D; Ling Z; Wu T; Zhao Y; Chang AH; Tong C; Liu S
BMC Cancer; 2022 Apr; 22(1):393. PubMed ID: 35410148
[TBL] [Abstract] [Full Text] [Related]
20. B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
Zhang S; Black RG; Kohli K; Hayes BJ; Miller C; Koehne A; Schroeder BA; Abrams K; Schulte BC; Alexiev BA; Heimberger AB; Zhang A; Jing W; Ng JCK; Shinglot H; Seguin B; Salter AI; Riddell SR; Jensen MC; Gottschalk S; Moore PF; Torok-Storb B; Pollack SM
Mol Cancer Ther; 2022 Jun; 21(6):999-1009. PubMed ID: 35405743
[TBL] [Abstract] [Full Text] [Related]
[Next]
